Taro`s Generic PEG-3350 Receives Approval in US
Taro Generic Diclofenac Potassium Receives Approval in US
Taro Pharma`s Generic Diclofenac Potassium Receives Approval in the U.S
Taro Generic Acyclovir Receives Approval in US
Taro shareholders approve merger with Sun Pharma
Taro Provides Results for Year Ended March 31, 2024
Ex-Sandoz exec gets probation for price-fixing after cooperation deal
Taro to Release Full Year Results on May 20, 2024